No safety issues have been identified, Moderna said about the lots that were distributed in Norway, Poland, Portugal, Spain and Sweden in January.
The drugmaker said the contamination was found in just one vial, and it was recalling the whole lot out of "an abundance of caution". It did not disclose what was found in the vial.
More about: coronavirus vaccine